Clearbridge Investments, LLC Morpho Sys Ag Transaction History

Clearbridge Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$18.95 - $23.95 $611,611 - $772,986	-32,275 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$21.56 - $30.66 $235,004 - $334,194	10,900 Added 50.99%	32,275 $704,000
Q4 2020 Feb 10, 2021	SELL	$24.81 - $30.33 $46,642 - $57,020	-1,880 Reduced 8.08%	21,375 $606,000
Q3 2020 Nov 12, 2020	BUY	$30.28 - $35.72 $71,460 - $84,299	2,360 Added 11.29%	23,255 $730,000
Q2 2020 Aug 14, 2020	BUY	$24.08 - $33.35 $135,136 - $187,160	5,612 Added 36.72%	20,895 $662,000

Q1 2020 May 15, 2020	BUY	$18.86 - $37.36 $288,237 - $570,972	15,283 New	15,283 $376,000

11.3M

320K

1.1M

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Market Cap $2.47B
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.